home · filing · 0001104659-23-082344
8-K filed July 19, 2023, 7:59 PM ET
ticker NXTC
CIK 0001661059
leadership
confidence high
sentiment neutral
materiality 0.45
NextCure director Garry A. Nicholson resigns effective August 15, 2023
NextCure, Inc.
Director Garry A. Nicholson resigned from NextCure's board, effective August 15, 2023.
Resignation not due to any disagreement with the company or its operations, policies or practices.
Mr. Nicholson's departure is a board-level change; no replacement named in the filing.
NextCure common stock trades on Nasdaq Global Select Market under ticker NXTC.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Garry A. Nicholson
Director
Effective 2023-08-15
Filed July 19, 2023, 7:59 PM ET
On July 15, 2023, Garry A. Nicholson resigned from the board of directors of NextCure, Inc. (the “Company”), effective August 15, 2023.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Garry A. Nicholson resigned as Director at NextCure, Inc..
Action resigned
Role Director
Exact text from the filing
On July 15, 2023, Garry A. Nicholson resigned from the board of directors of NextCure, Inc. (the “Company”), effective August 15, 2023.
View on SEC.gov
Source: SEC EDGAR
accession 0001104659-23-082344
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.